A significant contribution of our research is the identification of three central transcription factors, CEBPB, STAT3, and SPI1, which might be a mediator of AD gene regulation alterations and would have an impact on the pathogenesis of AD. This evidence concerns the gene STAT3 and Alzheimer disease.